0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Haemostatic Sponge Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-23V7461
Home | Market Reports
Global Medical Haemostatic Sponge Market Insights Forecast to 2028
BUY CHAPTERS

Global Medical Haemostatic Sponge Market Research Report 2026

Code: QYRE-Auto-23V7461
Report
2026-02-05
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Haemostatic Sponge Market Size

The global Medical Haemostatic Sponge market was valued at US$ 1620 million in 2025 and is anticipated to reach US$ 2109 million by 2032, at a CAGR of 4.1% from 2026 to 2032.

Medical Haemostatic Sponge Market

Medical Haemostatic Sponge Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Haemostatic Sponge competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Medical haemostatic sponges are topical hemostatic medical consumables used for local hemostasis in surgical or traumatic wounds. They achieve rapid hemostasis by absorbing blood and providing a porous scaffold to promote platelet aggregation and clot formation. Their material systems can include gelatin, collagen, oxidized regenerated cellulose, or composite matrices, emphasizing absorption speed and porosity to enhance hemostatic efficiency. Some products can be used in combination with thrombin to further enhance hemostatic effects. These products are widely used in general surgery, orthopedics, neurosurgery, ENT, dentistry, and emergency care. Key performance requirements include biocompatibility, sterility assurance, predictable absorbability or removability, low endotoxin levels, and controllable expansion to avoid pressure on surrounding tissues. The medical haemostatic sponge supply chain includes upstream bio-based polymer raw materials (gelatin/collagen/cellulose, etc.), purification reagents, cross-linking agents, medical-grade water, sterilization consumables, packaging materials, and labeling materials. The midstream manufacturing process encompasses raw material processing, foaming or freeze-drying to create porous structures, molding and cutting, drying, sterilization (using gamma or ethylene oxide), and quality testing for absorbency, endotoxins, bioburden, and mechanical integrity. Downstream users primarily include hospitals, surgical centers, trauma departments, and medical device distribution channels. Supporting services include clinical use training, regulatory documentation support, post-market surveillance, and aseptic logistics supply assurance.
Prices for Medical Haemostatic Sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10% – 30%.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report delivers a comprehensive overview of the global Medical Haemostatic Sponge market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Haemostatic Sponge. The Medical Haemostatic Sponge market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Haemostatic Sponge market comprehensively. Regional market sizes by Type, by Application, by Product Form, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Haemostatic Sponge manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Medical Haemostatic Sponge Market Report

Report Metric Details
Report Name Medical Haemostatic Sponge Market
Accounted market size in 2025 US$ 1620 million
Forecasted market size in 2032 US$ 2109 million
CAGR 4.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Gelatin Haemostatic Sponge
  • Collagen Haemostatic Sponge
  • Others
Segment by Product Form
  • Sponge Sheets
  • Sponge Particles
  • Others
Segment by Departments
  • ENT and Dental Surgery
  • Plastic Surgery
  • Neuro surgery
  • Others
by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product Form, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Haemostatic Sponge manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Medical Haemostatic Sponge sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Medical Haemostatic Sponge Market growing?

Ans: The Medical Haemostatic Sponge Market witnessing a CAGR of 4.1% during the forecast period 2026-2032.

What is the Medical Haemostatic Sponge Market size in 2032?

Ans: The Medical Haemostatic Sponge Market size in 2032 will be US$ 2109 million.

Who are the main players in the Medical Haemostatic Sponge Market report?

Ans: The main players in the Medical Haemostatic Sponge Market are Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, BOENMED, Medelast, JIAXING KENYUE, Medzeel Lifescience, Goodwill Lifesciences, Equimedical, Healthium Medtech, Septodont, Assut Europe, Nanchang Hushida Medical Technology

What are the Application segmentation covered in the Medical Haemostatic Sponge Market report?

Ans: The Applications covered in the Medical Haemostatic Sponge Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Medical Haemostatic Sponge Market report?

Ans: The Types covered in the Medical Haemostatic Sponge Market report are Gelatin Haemostatic Sponge, Collagen Haemostatic Sponge, Others

1 Medical Haemostatic Sponge Market Overview
1.1 Product Definition
1.2 Medical Haemostatic Sponge by Type
1.2.1 Global Medical Haemostatic Sponge Market Value by Type: 2025 vs 2032
1.2.2 Gelatin Haemostatic Sponge
1.2.3 Collagen Haemostatic Sponge
1.2.4 Others
1.3 Medical Haemostatic Sponge by Product Form
1.3.1 Global Medical Haemostatic Sponge Market Value by Product Form: 2025 vs 2032
1.3.2 Sponge Sheets
1.3.3 Sponge Particles
1.3.4 Others
1.4 Medical Haemostatic Sponge by Departments
1.4.1 Global Medical Haemostatic Sponge Market Value by Departments: 2025 vs 2032
1.4.2 ENT and Dental Surgery
1.4.3 Plastic Surgery
1.4.4 Neuro surgery
1.4.5 Others
1.5 Medical Haemostatic Sponge by Application
1.5.1 Global Medical Haemostatic Sponge Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Global Medical Haemostatic Sponge Market Size Estimates and Forecasts
1.6.1 Global Medical Haemostatic Sponge Revenue 2021–2032
1.6.2 Global Medical Haemostatic Sponge Sales 2021–2032
1.6.3 Global Medical Haemostatic Sponge Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Medical Haemostatic Sponge Market Competition by Manufacturers
2.1 Global Medical Haemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Haemostatic Sponge Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Haemostatic Sponge Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Haemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Haemostatic Sponge, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Haemostatic Sponge, Product Types and Applications
2.7 Global Key Manufacturers of Medical Haemostatic Sponge, Date of Entry into the Industry
2.8 Global Medical Haemostatic Sponge Market Competitive Situation and Trends
2.8.1 Global Medical Haemostatic Sponge Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Haemostatic Sponge Players Market Share by Revenue
2.8.3 Global Medical Haemostatic Sponge Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Haemostatic Sponge Market Scenario by Region
3.1 Global Medical Haemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Haemostatic Sponge Sales by Region: 2021–2032
3.2.1 Global Medical Haemostatic Sponge Sales by Region: 2021–2026
3.2.2 Global Medical Haemostatic Sponge Sales by Region: 2027–2032
3.3 Global Medical Haemostatic Sponge Revenue by Region: 2021–2032
3.3.1 Global Medical Haemostatic Sponge Revenue by Region: 2021–2026
3.3.2 Global Medical Haemostatic Sponge Revenue by Region: 2027–2032
3.4 North America Medical Haemostatic Sponge Market Facts & Figures by Country
3.4.1 North America Medical Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Haemostatic Sponge Sales by Country (2021–2032)
3.4.3 North America Medical Haemostatic Sponge Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Haemostatic Sponge Market Facts & Figures by Country
3.5.1 Europe Medical Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Haemostatic Sponge Sales by Country (2021–2032)
3.5.3 Europe Medical Haemostatic Sponge Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Haemostatic Sponge Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Haemostatic Sponge Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Haemostatic Sponge Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Haemostatic Sponge Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Haemostatic Sponge Market Facts & Figures by Country
3.7.1 Latin America Medical Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Haemostatic Sponge Sales by Country (2021–2032)
3.7.3 Latin America Medical Haemostatic Sponge Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Haemostatic Sponge Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Haemostatic Sponge Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Haemostatic Sponge Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Haemostatic Sponge Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Haemostatic Sponge Sales by Type (2021–2032)
4.1.1 Global Medical Haemostatic Sponge Sales by Type (2021–2026)
4.1.2 Global Medical Haemostatic Sponge Sales by Type (2027–2032)
4.1.3 Global Medical Haemostatic Sponge Sales Market Share by Type (2021–2032)
4.2 Global Medical Haemostatic Sponge Revenue by Type (2021–2032)
4.2.1 Global Medical Haemostatic Sponge Revenue by Type (2021–2026)
4.2.2 Global Medical Haemostatic Sponge Revenue by Type (2027–2032)
4.2.3 Global Medical Haemostatic Sponge Revenue Market Share by Type (2021–2032)
4.3 Global Medical Haemostatic Sponge Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Haemostatic Sponge Sales by Application (2021–2032)
5.1.1 Global Medical Haemostatic Sponge Sales by Application (2021–2026)
5.1.2 Global Medical Haemostatic Sponge Sales by Application (2027–2032)
5.1.3 Global Medical Haemostatic Sponge Sales Market Share by Application (2021–2032)
5.2 Global Medical Haemostatic Sponge Revenue by Application (2021–2032)
5.2.1 Global Medical Haemostatic Sponge Revenue by Application (2021–2026)
5.2.2 Global Medical Haemostatic Sponge Revenue by Application (2027–2032)
5.2.3 Global Medical Haemostatic Sponge Revenue Market Share by Application (2021–2032)
5.3 Global Medical Haemostatic Sponge Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Medical Haemostatic Sponge Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Johnson & Johnson Medical Haemostatic Sponge Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Company Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 B. Braun Medical Haemostatic Sponge Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Gelita Medical
6.4.1 Gelita Medical Company Information
6.4.2 Gelita Medical Description and Business Overview
6.4.3 Gelita Medical Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Gelita Medical Medical Haemostatic Sponge Product Portfolio
6.4.5 Gelita Medical Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cura Medical Medical Haemostatic Sponge Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 Aegis Lifesciences
6.6.1 Aegis Lifesciences Company Information
6.6.2 Aegis Lifesciences Description and Business Overview
6.6.3 Aegis Lifesciences Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aegis Lifesciences Medical Haemostatic Sponge Product Portfolio
6.6.5 Aegis Lifesciences Recent Developments/Updates
6.7 COLTENE
6.7.1 COLTENE Company Information
6.7.2 COLTENE Description and Business Overview
6.7.3 COLTENE Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 COLTENE Medical Haemostatic Sponge Product Portfolio
6.7.5 COLTENE Recent Developments/Updates
6.8 Dispotech
6.8.1 Dispotech Company Information
6.8.2 Dispotech Description and Business Overview
6.8.3 Dispotech Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Dispotech Medical Haemostatic Sponge Product Portfolio
6.8.5 Dispotech Recent Developments/Updates
6.9 Ferrosan Medical Devices
6.9.1 Ferrosan Medical Devices Company Information
6.9.2 Ferrosan Medical Devices Description and Business Overview
6.9.3 Ferrosan Medical Devices Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ferrosan Medical Devices Medical Haemostatic Sponge Product Portfolio
6.9.5 Ferrosan Medical Devices Recent Developments/Updates
6.10 EUCARE Pharmaceuticals
6.10.1 EUCARE Pharmaceuticals Company Information
6.10.2 EUCARE Pharmaceuticals Description and Business Overview
6.10.3 EUCARE Pharmaceuticals Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 EUCARE Pharmaceuticals Medical Haemostatic Sponge Product Portfolio
6.10.5 EUCARE Pharmaceuticals Recent Developments/Updates
6.11 BOENMED
6.11.1 BOENMED Company Information
6.11.2 BOENMED Description and Business Overview
6.11.3 BOENMED Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BOENMED Medical Haemostatic Sponge Product Portfolio
6.11.5 BOENMED Recent Developments/Updates
6.12 Medelast
6.12.1 Medelast Company Information
6.12.2 Medelast Description and Business Overview
6.12.3 Medelast Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Medelast Medical Haemostatic Sponge Product Portfolio
6.12.5 Medelast Recent Developments/Updates
6.13 JIAXING KENYUE
6.13.1 JIAXING KENYUE Company Information
6.13.2 JIAXING KENYUE Description and Business Overview
6.13.3 JIAXING KENYUE Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JIAXING KENYUE Medical Haemostatic Sponge Product Portfolio
6.13.5 JIAXING KENYUE Recent Developments/Updates
6.14 Medzeel Lifescience
6.14.1 Medzeel Lifescience Company Information
6.14.2 Medzeel Lifescience Description and Business Overview
6.14.3 Medzeel Lifescience Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Medzeel Lifescience Medical Haemostatic Sponge Product Portfolio
6.14.5 Medzeel Lifescience Recent Developments/Updates
6.15 Goodwill Lifesciences
6.15.1 Goodwill Lifesciences Company Information
6.15.2 Goodwill Lifesciences Description and Business Overview
6.15.3 Goodwill Lifesciences Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Goodwill Lifesciences Medical Haemostatic Sponge Product Portfolio
6.15.5 Goodwill Lifesciences Recent Developments/Updates
6.16 Equimedical
6.16.1 Equimedical Company Information
6.16.2 Equimedical Description and Business Overview
6.16.3 Equimedical Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Equimedical Medical Haemostatic Sponge Product Portfolio
6.16.5 Equimedical Recent Developments/Updates
6.17 Healthium Medtech
6.17.1 Healthium Medtech Company Information
6.17.2 Healthium Medtech Description and Business Overview
6.17.3 Healthium Medtech Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Healthium Medtech Medical Haemostatic Sponge Product Portfolio
6.17.5 Healthium Medtech Recent Developments/Updates
6.18 Septodont
6.18.1 Septodont Company Information
6.18.2 Septodont Description and Business Overview
6.18.3 Septodont Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Septodont Medical Haemostatic Sponge Product Portfolio
6.18.5 Septodont Recent Developments/Updates
6.19 Assut Europe
6.19.1 Assut Europe Company Information
6.19.2 Assut Europe Description and Business Overview
6.19.3 Assut Europe Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Assut Europe Medical Haemostatic Sponge Product Portfolio
6.19.5 Assut Europe Recent Developments/Updates
6.20 Nanchang Hushida Medical Technology
6.20.1 Nanchang Hushida Medical Technology Company Information
6.20.2 Nanchang Hushida Medical Technology Description and Business Overview
6.20.3 Nanchang Hushida Medical Technology Medical Haemostatic Sponge Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Nanchang Hushida Medical Technology Medical Haemostatic Sponge Product Portfolio
6.20.5 Nanchang Hushida Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Haemostatic Sponge Industry Chain Analysis
7.2 Medical Haemostatic Sponge Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Haemostatic Sponge Production Mode & Process Analysis
7.4 Medical Haemostatic Sponge Sales and Marketing
7.4.1 Medical Haemostatic Sponge Sales Channels
7.4.2 Medical Haemostatic Sponge Distributors
7.5 Medical Haemostatic Sponge Customer Analysis
8 Medical Haemostatic Sponge Market Dynamics
8.1 Medical Haemostatic Sponge Industry Trends
8.2 Medical Haemostatic Sponge Market Drivers
8.3 Medical Haemostatic Sponge Market Challenges
8.4 Medical Haemostatic Sponge Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medical Haemostatic Sponge Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Medical Haemostatic Sponge Market Value by Product Form (US$ Million), 2025 vs 2032
 Table 3. Global Medical Haemostatic Sponge Market Value by Departments (US$ Million), 2025 vs 2032
 Table 4. Global Medical Haemostatic Sponge Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Medical Haemostatic Sponge Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Medical Haemostatic Sponge Sales (K Units) of Key Manufacturers (2021–2026)
 Table 7. Global Medical Haemostatic Sponge Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Medical Haemostatic Sponge Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Medical Haemostatic Sponge Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Medical Haemostatic Sponge Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Medical Haemostatic Sponge, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Medical Haemostatic Sponge, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Medical Haemostatic Sponge, Product Types and Applications
 Table 14. Global Key Manufacturers of Medical Haemostatic Sponge, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Medical Haemostatic Sponge Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Haemostatic Sponge Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Medical Haemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Medical Haemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 20. Global Medical Haemostatic Sponge Sales Market Share by Region (2021–2026)
 Table 21. Global Medical Haemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 22. Global Medical Haemostatic Sponge Sales Market Share by Region (2027–2032)
 Table 23. Global Medical Haemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Medical Haemostatic Sponge Revenue Market Share by Region (2021–2026)
 Table 25. Global Medical Haemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Medical Haemostatic Sponge Revenue Market Share by Region (2027–2032)
 Table 27. North America Medical Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Medical Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 29. North America Medical Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 30. North America Medical Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Medical Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Medical Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Medical Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 34. Europe Medical Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 35. Europe Medical Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Medical Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Medical Haemostatic Sponge Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Medical Haemostatic Sponge Sales by Region (K Units), 2021–2026
 Table 39. Asia Pacific Medical Haemostatic Sponge Sales by Region (K Units), 2027–2032
 Table 40. Asia Pacific Medical Haemostatic Sponge Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Medical Haemostatic Sponge Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Medical Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Medical Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 44. Latin America Medical Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 45. Latin America Medical Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Medical Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Medical Haemostatic Sponge Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Medical Haemostatic Sponge Sales by Country (K Units), 2021–2026
 Table 49. Middle East and Africa Medical Haemostatic Sponge Sales by Country (K Units), 2027–2032
 Table 50. Middle East and Africa Medical Haemostatic Sponge Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Medical Haemostatic Sponge Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Medical Haemostatic Sponge Sales (K Units) by Type (2021–2026)
 Table 53. Global Medical Haemostatic Sponge Sales (K Units) by Type (2027–2032)
 Table 54. Global Medical Haemostatic Sponge Sales Market Share by Type (2021–2026)
 Table 55. Global Medical Haemostatic Sponge Sales Market Share by Type (2027–2032)
 Table 56. Global Medical Haemostatic Sponge Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Medical Haemostatic Sponge Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Medical Haemostatic Sponge Revenue Market Share by Type (2021–2026)
 Table 59. Global Medical Haemostatic Sponge Revenue Market Share by Type (2027–2032)
 Table 60. Global Medical Haemostatic Sponge Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Medical Haemostatic Sponge Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Medical Haemostatic Sponge Sales (K Units) by Application (2021–2026)
 Table 63. Global Medical Haemostatic Sponge Sales (K Units) by Application (2027–2032)
 Table 64. Global Medical Haemostatic Sponge Sales Market Share by Application (2021–2026)
 Table 65. Global Medical Haemostatic Sponge Sales Market Share by Application (2027–2032)
 Table 66. Global Medical Haemostatic Sponge Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Medical Haemostatic Sponge Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Medical Haemostatic Sponge Revenue Market Share by Application (2021–2026)
 Table 69. Global Medical Haemostatic Sponge Revenue Market Share by Application (2027–2032)
 Table 70. Global Medical Haemostatic Sponge Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Medical Haemostatic Sponge Price (US$/Unit) by Application (2027–2032)
 Table 72. Pfizer Company Information
 Table 73. Pfizer Description and Business Overview
 Table 74. Pfizer Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Pfizer Medical Haemostatic Sponge Product
 Table 76. Pfizer Recent Developments/Updates
 Table 77. Johnson & Johnson Company Information
 Table 78. Johnson & Johnson Description and Business Overview
 Table 79. Johnson & Johnson Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Johnson & Johnson Medical Haemostatic Sponge Product
 Table 81. Johnson & Johnson Recent Developments/Updates
 Table 82. B. Braun Company Information
 Table 83. B. Braun Description and Business Overview
 Table 84. B. Braun Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. B. Braun Medical Haemostatic Sponge Product
 Table 86. B. Braun Recent Developments/Updates
 Table 87. Gelita Medical Company Information
 Table 88. Gelita Medical Description and Business Overview
 Table 89. Gelita Medical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Gelita Medical Medical Haemostatic Sponge Product
 Table 91. Gelita Medical Recent Developments/Updates
 Table 92. Cura Medical Company Information
 Table 93. Cura Medical Description and Business Overview
 Table 94. Cura Medical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Cura Medical Medical Haemostatic Sponge Product
 Table 96. Cura Medical Recent Developments/Updates
 Table 97. Aegis Lifesciences Company Information
 Table 98. Aegis Lifesciences Description and Business Overview
 Table 99. Aegis Lifesciences Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Aegis Lifesciences Medical Haemostatic Sponge Product
 Table 101. Aegis Lifesciences Recent Developments/Updates
 Table 102. COLTENE Company Information
 Table 103. COLTENE Description and Business Overview
 Table 104. COLTENE Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. COLTENE Medical Haemostatic Sponge Product
 Table 106. COLTENE Recent Developments/Updates
 Table 107. Dispotech Company Information
 Table 108. Dispotech Description and Business Overview
 Table 109. Dispotech Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Dispotech Medical Haemostatic Sponge Product
 Table 111. Dispotech Recent Developments/Updates
 Table 112. Ferrosan Medical Devices Company Information
 Table 113. Ferrosan Medical Devices Description and Business Overview
 Table 114. Ferrosan Medical Devices Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Ferrosan Medical Devices Medical Haemostatic Sponge Product
 Table 116. Ferrosan Medical Devices Recent Developments/Updates
 Table 117. EUCARE Pharmaceuticals Company Information
 Table 118. EUCARE Pharmaceuticals Description and Business Overview
 Table 119. EUCARE Pharmaceuticals Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. EUCARE Pharmaceuticals Medical Haemostatic Sponge Product
 Table 121. EUCARE Pharmaceuticals Recent Developments/Updates
 Table 122. BOENMED Company Information
 Table 123. BOENMED Description and Business Overview
 Table 124. BOENMED Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. BOENMED Medical Haemostatic Sponge Product
 Table 126. BOENMED Recent Developments/Updates
 Table 127. Medelast Company Information
 Table 128. Medelast Description and Business Overview
 Table 129. Medelast Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Medelast Medical Haemostatic Sponge Product
 Table 131. Medelast Recent Developments/Updates
 Table 132. JIAXING KENYUE Company Information
 Table 133. JIAXING KENYUE Description and Business Overview
 Table 134. JIAXING KENYUE Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. JIAXING KENYUE Medical Haemostatic Sponge Product
 Table 136. JIAXING KENYUE Recent Developments/Updates
 Table 137. Medzeel Lifescience Company Information
 Table 138. Medzeel Lifescience Description and Business Overview
 Table 139. Medzeel Lifescience Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. Medzeel Lifescience Medical Haemostatic Sponge Product
 Table 141. Medzeel Lifescience Recent Developments/Updates
 Table 142. Goodwill Lifesciences Company Information
 Table 143. Goodwill Lifesciences Description and Business Overview
 Table 144. Goodwill Lifesciences Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Goodwill Lifesciences Medical Haemostatic Sponge Product
 Table 146. Goodwill Lifesciences Recent Developments/Updates
 Table 147. Equimedical Company Information
 Table 148. Equimedical Description and Business Overview
 Table 149. Equimedical Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 150. Equimedical Medical Haemostatic Sponge Product
 Table 151. Equimedical Recent Developments/Updates
 Table 152. Healthium Medtech Company Information
 Table 153. Healthium Medtech Description and Business Overview
 Table 154. Healthium Medtech Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 155. Healthium Medtech Medical Haemostatic Sponge Product
 Table 156. Healthium Medtech Recent Developments/Updates
 Table 157. Septodont Company Information
 Table 158. Septodont Description and Business Overview
 Table 159. Septodont Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 160. Septodont Medical Haemostatic Sponge Product
 Table 161. Septodont Recent Developments/Updates
 Table 162. Assut Europe Company Information
 Table 163. Assut Europe Description and Business Overview
 Table 164. Assut Europe Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 165. Assut Europe Medical Haemostatic Sponge Product
 Table 166. Assut Europe Recent Developments/Updates
 Table 167. Nanchang Hushida Medical Technology Company Information
 Table 168. Nanchang Hushida Medical Technology Description and Business Overview
 Table 169. Nanchang Hushida Medical Technology Medical Haemostatic Sponge Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 170. Nanchang Hushida Medical Technology Medical Haemostatic Sponge Product
 Table 171. Nanchang Hushida Medical Technology Recent Developments/Updates
 Table 172. Key Raw Materials Lists
 Table 173. Raw Materials Key Suppliers Lists
 Table 174. Medical Haemostatic Sponge Distributors List
 Table 175. Medical Haemostatic Sponge Customers List
 Table 176. Medical Haemostatic Sponge Market Trends
 Table 177. Medical Haemostatic Sponge Market Drivers
 Table 178. Medical Haemostatic Sponge Market Challenges
 Table 179. Medical Haemostatic Sponge Market Restraints
 Table 180. Research Programs/Design for This Report
 Table 181. Key Data Information from Secondary Sources
 Table 182. Key Data Information from Primary Sources
 Table 183. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Haemostatic Sponge
 Figure 2. Global Medical Haemostatic Sponge Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Medical Haemostatic Sponge Market Share by Type: 2025 & 2032
 Figure 4. Gelatin Haemostatic Sponge Product Picture
 Figure 5. Collagen Haemostatic Sponge Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Medical Haemostatic Sponge Market Value by Product Form (US$ Million), 2021–2032
 Figure 8. Global Medical Haemostatic Sponge Market Share by Product Form: 2025 vs 2032
 Figure 9. Sponge Sheets Product Picture
 Figure 10. Sponge Particles Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Medical Haemostatic Sponge Market Value by Departments (US$ Million), 2021–2032
 Figure 13. Global Medical Haemostatic Sponge Market Share by Departments: 2025 vs 2032
 Figure 14. ENT and Dental Surgery Product Picture
 Figure 15. Plastic Surgery Product Picture
 Figure 16. Neuro surgery Product Picture
 Figure 17. Others Product Picture
 Figure 18. Global Medical Haemostatic Sponge Market Value by Application (US$ Million), 2021–2032
 Figure 19. Global Medical Haemostatic Sponge Market Share by Application: 2025 & 2032
 Figure 20. Hospitals
 Figure 21. Clinics
 Figure 22. Others
 Figure 23. Global Medical Haemostatic Sponge Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 24. Global Medical Haemostatic Sponge Market Size (US$ Million), 2021–2032
 Figure 25. Global Medical Haemostatic Sponge Sales (K Units), 2021–2032
 Figure 26. Global Medical Haemostatic Sponge Average Price (US$/Unit), 2021–2032
 Figure 27. Medical Haemostatic Sponge Report Years Considered
 Figure 28. Medical Haemostatic Sponge Sales Share by Manufacturers in 2025
 Figure 29. Global Medical Haemostatic Sponge Revenue Share by Manufacturers in 2025
 Figure 30. Top 5 and Top 10 Global Medical Haemostatic Sponge Players: Market Share by Revenue in Medical Haemostatic Sponge in 2025
 Figure 31. Medical Haemostatic Sponge Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 32. Global Medical Haemostatic Sponge Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 33. North America Medical Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 34. North America Medical Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 35. U.S. Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Canada Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Europe Medical Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 38. Europe Medical Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 39. Germany Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. France Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. U.K. Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Italy Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Russia Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Asia Pacific Medical Haemostatic Sponge Sales Market Share by Region (2021–2032)
 Figure 45. Asia Pacific Medical Haemostatic Sponge Revenue Market Share by Region (2021–2032)
 Figure 46. China Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Japan Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. South Korea Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. India Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Australia Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Taiwan Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Indonesia Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Thailand Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Malaysia Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Philippines Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Latin America Medical Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 57. Latin America Medical Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 58. Mexico Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Brazil Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Argentina Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Middle East and Africa Medical Haemostatic Sponge Sales Market Share by Country (2021–2032)
 Figure 62. Middle East and Africa Medical Haemostatic Sponge Revenue Market Share by Country (2021–2032)
 Figure 63. Turkey Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 64. Saudi Arabia Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. UAE Medical Haemostatic Sponge Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. Global Sales Market Share of Medical Haemostatic Sponge by Type (2021–2032)
 Figure 67. Global Revenue Market Share of Medical Haemostatic Sponge by Type (2021–2032)
 Figure 68. Global Medical Haemostatic Sponge Price (US$/Unit) by Type (2021–2032)
 Figure 69. Global Sales Market Share of Medical Haemostatic Sponge by Application (2021–2032)
 Figure 70. Global Revenue Market Share of Medical Haemostatic Sponge by Application (2021–2032)
 Figure 71. Global Medical Haemostatic Sponge Price (US$/Unit) by Application (2021–2032)
 Figure 72. Medical Haemostatic Sponge Value Chain
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS